We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

13 hedge funds and large institutions have $220K invested in GeneDx Holdings Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.84% more ownership

Funds ownership: 10.1%10.95% (+0.84%)

7% less funds holding

Funds holding: 1413 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

63% less capital invested

Capital invested by funds: $595K → $220K (-$375K)

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
2
Calls
$16K
Puts
Net Calls
+$16K
Net Calls Change
-$29K

WGSWW Hedge Fund Activity: Q2 2025 in Review

13 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2025, worth a combined $220K — down 63% from $595K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of WGSWW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was LMR Partners, adding an estimated $29.7K. The largest seller was UBS Group, cutting an estimated $9.18K.

  • 13 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2025, down from 14 in Q1 2025.
  • Funds reported $220K of GeneDx Holdings Warrant stock for Q2 2025, down 63% quarter-over-quarter.
  • 1 fund opened new GeneDx Holdings Warrant positions in Q2 2025 and 2 closed out, a net change of -1 holder.
  • The largest GeneDx Holdings Warrant buyer in Q2 2025 was LMR Partners, an estimated $29.7K added.
  • The largest GeneDx Holdings Warrant seller in Q2 2025 was UBS Group, an estimated $9.18K sold.

Based on aggregated 13F filings for Q2 2025.